Good User Reputation for Clindamycin Gentamicin - dexamethasone sodium phosphate injection – Xinanran
Good User Reputation for Clindamycin Gentamicin - dexamethasone sodium phosphate injection – Xinanran Detail:
[ Adverse reaction ] (1) There were strong water and sodium retention and potassium excretion.
(2) Has strong immunosuppressive effect.
(3) High dose use in late pregnancy might cause abortion.
[ Notice ] (1) It is contra-indicated in pregnant animals at earlier or late stages.
(2) In case of bacterial infections it should be combined with antimicrobial agents.
(3) Long-term medication should not be discontinued suddenly, the dosage gradually reduced until discontinuation.
[Withdrawal period] Cattle, sheep and pigs 21 days; The milk abandonment period is 72 hours.
[ Specification ] (1) 1ml:1mg (2) 5ml:5mg
[Storage] Shading the light and keeping it in a closed manner.
[Period of validity] Two years
[Manufacturing enterprise ] Hebei XinAnRan Biotechnology Co., Ltd
[Factory address] No. 6 First Row East, Konggang Street Economic Development Zone, Xinle City, Hebei Province.
Product detail pictures:
Related Product Guide:
We take "customer-friendly, quality-oriented, integrative, innovative" as objectives. "Truth and honesty" is our administration ideal for Good User Reputation for Clindamycin Gentamicin - dexamethasone sodium phosphate injection – Xinanran , The product will supply to all over the world, such as: Ethiopia, Paraguay, Venezuela, Products have been exported to Asia, Mid-east,European and Germany market. Our company has constantly been able to update the products performance and safety to meet the markets and strive to be top A on stable quality and sincere service. If you have the honor to do business with our company. we will definitely do our very best to support your business in China.
By Geraldine from Ethiopia - 2017.07.28 15:46
The company leader recept us warmly, through a meticulous and thorough discussion, we signed a purchase order. Hope to cooperate smoothly
By Jean from Morocco - 2018.09.16 11:31